Search research articles
Contact Us
Filters
Showing results (221-230 of 247) with videos related to
Page
of 25
Sort By:
The British Journal of Dermatology
|
February 3, 2016
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndrome
F Child, P L Ortiz-Romero, R Alvarez, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2023
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas
E Toulemonde, S Chevret, M Battistella, et al.
Clinical and Experimental Dermatology
|
May 14, 2021
Lymphomatoid papulosis types D and E: a multicentre series of the French Cutaneous Lymphomas Study Group
C Bergqvist, M Beylot-Barry, C Ram-Wolff, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 21, 2014
Folliculotropic T-cell infiltrates associated with B-cell chronic lymphocytic leukaemia or MALT lymphoma may reveal either true mycosis fungoides or pseudolymphomatous reaction: seven cases and review of the literature
S Ingen-Housz-Oro, N Franck, N Beneton, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 28, 2012
Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm
Z Reguiai, J B Bachet, C Bachmeyer, et al.
Blood
|
March 25, 2000
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas
B Vergier, A de Muret, M Beylot-Barry, et al.
International Journal of Cancer
|
June 22, 2000
Delays in diagnosis and melanoma prognosis (I): the role of patients
M A Richard, J J Grob, M F Avril, et al.
The British Journal of Dermatology
|
March 6, 2019
Cutaneous lymphomas appearing during treatment with biologics: 44 cases from the French Study Group on Cutaneous Lymphomas and French Pharmacovigilance Database
L Dequidt, N Franck, P Sanchez-Pena, et al.
The British Journal of Dermatology
|
July 7, 2020
Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing
L Le Cleach, L Dousset, H Assier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 14, 2017
Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort
E Sbidian, C Giboin, H Bachelez, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 247) with videos related to
Sort By:
Page
of 25
The British Journal of Dermatology
|
February 3, 2016
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndrome
F Child, P L Ortiz-Romero, R Alvarez, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2023
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas
E Toulemonde, S Chevret, M Battistella, et al.
Clinical and Experimental Dermatology
|
May 14, 2021
Lymphomatoid papulosis types D and E: a multicentre series of the French Cutaneous Lymphomas Study Group
C Bergqvist, M Beylot-Barry, C Ram-Wolff, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 21, 2014
Folliculotropic T-cell infiltrates associated with B-cell chronic lymphocytic leukaemia or MALT lymphoma may reveal either true mycosis fungoides or pseudolymphomatous reaction: seven cases and review of the literature
S Ingen-Housz-Oro, N Franck, N Beneton, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 28, 2012
Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm
Z Reguiai, J B Bachet, C Bachmeyer, et al.
Blood
|
March 25, 2000
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas
B Vergier, A de Muret, M Beylot-Barry, et al.
International Journal of Cancer
|
June 22, 2000
Delays in diagnosis and melanoma prognosis (I): the role of patients
M A Richard, J J Grob, M F Avril, et al.
The British Journal of Dermatology
|
March 6, 2019
Cutaneous lymphomas appearing during treatment with biologics: 44 cases from the French Study Group on Cutaneous Lymphomas and French Pharmacovigilance Database
L Dequidt, N Franck, P Sanchez-Pena, et al.
The British Journal of Dermatology
|
July 7, 2020
Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing
L Le Cleach, L Dousset, H Assier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 14, 2017
Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort
E Sbidian, C Giboin, H Bachelez, et al.
Page
of 25